These peptides exhibit significant potential in selectively binding to differentially expressed cell surface receptors and proteins, including immune checkpoints, receptor kinases, and hormone receptors in cancer, thereby effectively inhibiting their biological activity [49]. The gene discussed is CD177; the disease is cancer.